| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.05 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.06 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.06 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.059 | 0.07 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.09 | 0.07 |